2006
DOI: 10.1016/j.urology.2006.06.007
|View full text |Cite
|
Sign up to set email alerts
|

Extracorporeal renal lithotripsy: Evolution of residual lithiasis treated with thiazides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(16 citation statements)
references
References 10 publications
0
16
0
Order By: Relevance
“…Because of the effects of thiazides to lower urinary calcium excretion, thiazides are also used to prevent recurrence of calcium nephrolithiasis, especially in hypercalciuric subjects [25]. Thiazide treatment is associated with a positive calcium balance with an increase in cortical bone mineral density and therefore has been used to treat osteoporosis and prevent fractures in postmenopausal women [26-28].…”
Section: Clinical Uses Of Thiazidesmentioning
confidence: 99%
“…Because of the effects of thiazides to lower urinary calcium excretion, thiazides are also used to prevent recurrence of calcium nephrolithiasis, especially in hypercalciuric subjects [25]. Thiazide treatment is associated with a positive calcium balance with an increase in cortical bone mineral density and therefore has been used to treat osteoporosis and prevent fractures in postmenopausal women [26-28].…”
Section: Clinical Uses Of Thiazidesmentioning
confidence: 99%
“…Thiazides can be effective in both normocalciuric and hypercalciuric patients. The beneficial effects have been confirmed in several studies 6,7 over the last 55 years and are summarized in the recent AUA guideline on medical management of kidney stones 5 . Thiazides directly stimulate calcium resorption in the distal nephron while reducing the 3 extracellular fluid compartment.…”
Section: Thiazidesmentioning
confidence: 73%
“…Genetic studies have revealed this relationship among CLDN14 gen modifications, osteoporosis, and nephrolithiasis [3]. For some years, thiazides have been used for treatment of calcium lithiasis with hypercalciuria, producing excellent results [17,18]; but, it has also been observed that this therapy, although it decreases calciuria and with that the risk of nephrolithiasis formation, does not improve bone mineral density in comparison with usual supplements of calcium and vitamine D. Therefore, it is not indicated for monotherapy in patients with hypercalciuria, calcium lithiasis, and loss of bone mass [19]. The use of alendronate, nonetheless, has proven to decrease calciuria in combination with improvement in bone mineral density.…”
Section: Discussionmentioning
confidence: 99%